Sol-Gel Technologies Ltd.

IPO

Harnessing Dermatological Innovation

Sol-Gel Technologies Ltd. is a biotech company in Ness Ziona. It has 2 recorded funding rounds.

Headquarters
Ness Ziona
Business Model
B2B
Rounds
2
Type
Public

Indexed holds 2 funding rounds and 4 investors for this company. to use credits for reveals, or explore the API.

About

Sol-Gel Technologies is a NASDAQ-listed (SLGL) dermatology company leveraging proprietary microencapsulation and formulation technology to develop and commercialize advanced treatments for patients with severe and rare skin conditions, including two FDA-approved products, TWYNEO and EPSOLAY. The company's pipeline extends into additional indications such as Gorlin Syndrome and high-frequency basal cell carcinoma, and it partners with established commercial leaders to accelerate global product rollout.

Funding & Exit History

Data from Indexed.vcUpdated
Secondary MarketSecondary MarketMay 2026

5 more events

  • Secondary Market2023
  • Secondary Market2020
  • IPO2018

Funding, valuations, and company events, with amounts and investors where available.

Investors

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sol-Gel Technologies Ltd. on Indexed.vc
<a href="https://indexed.vc/companies/sol-gel-technologies-ltd"><img src="https://indexed.vc/api/badge/company/sol-gel-technologies-ltd" alt="Sol-Gel Technologies Ltd. on Indexed.vc" width="260" height="76" /></a>